Tien Liang BioTech Co., Ltd. (TPEX:4127)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
36.90
+0.90 (2.50%)
Mar 10, 2026, 12:44 PM CST
-5.38%
Market Cap 1.65B
Revenue (ttm) 467.02M
Net Income (ttm) -3.25M
Shares Out 45.76M
EPS (ttm) -0.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,000
Average Volume 143,787
Open 36.40
Previous Close 36.00
Day's Range 36.15 - 37.40
52-Week Range 29.00 - 42.20
Beta 0.52
RSI 48.13
Earnings Date Mar 13, 2026

About Tien Liang BioTech

Tien Liang BioTech Co., Ltd. manufactures and sells pharmaceutical products in Taiwan. The company offers Chinese medicine products, such as pills for liver and kidney deficiency, lower back pain and sore feet, dizziness and blurred vision, thirst, dry tongue and sore throat, and heel pain, as well as rheumatic pain, joint pain, generalized pain, wind-cold-dampness arthralgia, gout, neuralgia, bedwetting, hemorrhoids, and constipation indications; resolving and cough-relieving powder for colds, coughs, bronchitis, cough suppressants, and expect... [Read more]

Sector Healthcare
Founded 1971
Employees 88
Stock Exchange Taipei Exchange
Ticker Symbol 4127
Full Company Profile

Financial Performance

In 2024, Tien Liang BioTech's revenue was 385.21 million, a decrease of -16.26% compared to the previous year's 459.99 million. Earnings were 11.70 million, a decrease of -34.04%.

Financial Statements

News

There is no news available yet.